Fake Busters: Honeywell’s Tech To Identify Counterfeit Drugs

Mumbai : The coronavirus pandemic, the biggest public health crisis in recent times, continues to haunt Indians, especially as we remember the plight of critically ill patients and unfortunate deaths in the months of April and May. An acute shortage of drugs to treat symptoms of Covid-19 led to increased circulation of counterfeit medicines in recent times. There were even reports of fake antiviral medicines and spurious injectable immuno suppressant in the market, jeopardising the lives of patients, and even leading to fatalities. Interpol’s Operation Pangea reported a rise in fake medical products related to the pandemic, with 4.4 million units valued at $14 million seized in 2020 alone.

With rising demand for vaccines, there is concern that fake vaccines could find their way into circulation. Earlier this year, the World Health Organisation sounded an alarm over criminal exploitation of an unmet global demand for Covid-19 vaccines. Already, counterfeit vaccines have been detected in countries such as Mexico and Poland.

In order to overcome this, Honeywell has introduced digital authentication technology for pharmaceutical products in a bid to fight rising counterfeit crime in India. “Honeywell is deploying its authentication technology for the pharmaceutical industry in response to the growing menace of counterfeit products,” said Hitesh Mehta, general manager, Advanced Materials, Honeywell India. “Our sophisticated authentication technologies feature printing and substrates which can be easily identified but are difficult to alter and duplicate. Our technology offers brand protection for manufacturers and assurance of authentic products for end users.”

The solution comprises a digital code that is embedded in the packaging of pharmaceutical products. The end user can validate the authenticity of the product by scanning the digital code with the help of a smartphone. The software that validates the product’s authenticity through a database is accessible through a Honeywell app available for download for iOS and Android users and gathers market intelligence.

  • Related Posts

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    Meerut: A four-year-old boy’s condition allegedly worsened after he was administered an anti-rabies injection at Sambhal district hospital following a snakebite. A pharmacist at the hospital has been removed from…

    Lupin gets tentative US FDA nod for apixaban oral suspension for patients who cannot swallow tablets

    Once final approval comes through, the liquid anticoagulant will be made at Lupin’s plant in Somerset, New Jersey, the company said. Mumbai: Lupin has received tentative approval from the US…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

    Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

    Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

    Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

    Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

    Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

    Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

    Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

    Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore

    Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore